Journal of Diabetes and Its Complications
Volume 25, Issue 1 , Pages 7-13 , January 2011

Association between hemoglobin A1c, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in Korean type 2 diabetic patients

  • Seong-Woo Choi

      Affiliations

    • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea
    • ,
  • Min-Ho Shin

      Affiliations

    • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea
    • ,
  • Woo-Jun Yun

      Affiliations

    • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea
    • ,
  • Hey-Yeon Kim

      Affiliations

    • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea
    • ,
  • Young-Hoon Lee

      Affiliations

    • Department of Preventive Medicine, Seonam University College of Medicine, Jeollabukdo 590-711, Republic of Korea
    • ,
  • Sun-Seog Kweon

      Affiliations

    • Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital, Jeollanamdo 519-809, Republic of Korea
    • ,
  • Jung-Ae Rhee

      Affiliations

    • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 62 220 4163; fax: +82 62 233 0305.
    • ,
  • Jin-Su Choi

      Affiliations

    • Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea

Received 12 October 2009 ,Revised 4 November 2009 ,Accepted 2 December 2009.

References 

  1. Adler AI, Stevens RJ, et al. UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002;25(5):894–899
  2. Adler AI, Stratton IM, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412–419
  3. Androulakis AE, Andrikopoulos GK, et al. The role of carotid atherosclerosis in the distinction between ischemic and non-ischemic cardiomyopathy. European Heart Journal. 2000;21:919–926
  4. Aronow WS, Ahn C, et al. Relation of increased hemoglobin A1c levels to severity of peripheral arterial disease in patients with diabetes mellitus. American Journal of Cardiology. 2007;99(10):1468–1469
  5. Benetos A, Laurent S, et al. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arteriosclerosis and Thrombosis. 1993;13:90–97
  6. Blacher J, Asmar R, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33(5):1111–1117
  7. Blacher J, Guerin AP, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434–2439
  8. Bonithon-Kopp C, Touboul P-J, et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries: The Vascular Aging (EVA) Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16(2):310–316
  9. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: The epidemiological evidence. Diabetologia. 2001;44:2107–2111
  10. Bowie A, Owens D, et al. Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient?. Atherosclerosis. 1993;102(1):63–67
  11. Bunn H, Gabbay K, et al. The glycosylation of hemoglobin: Relevance to diabetes mellitus. Science. 1978;200(4337):21–27
  12. Ceriello A, Quatraro A, et al. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Medicine. 1992;9(3):297–299
  13. Chambless LE, Folsom AR, et al. Carotid wall thickness is predictive of incident clinical stroke. The Atherosclerosis Risk in Communities (ARIC) study. American Journal of Epidemiology. 2000;151:478–487
  14. de Vegt F, Dekker JM, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study. Diabetologia. 1999;42(8):926–931
  15. Forrest KYZ, Becker DJ, et al. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis. 2000;148(1):159–169
  16. Friedewald WT, Levy RI, et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18(6):499–502
  17. Genuth S, Fastman R, Kahn R, Klein R, Lachin J, Lebovitz H, et al. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 2003;26(suppl 1):s28–s32
  18. Golledge J, Greenhalgh RM, et al. The symptomatic carotid plaque. Stroke. 2000;(31):774–781
  19. Goya K, Kitamura T, et al. Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications. Metabolism: Clinical and Experimental. 2003;52(10):1302–1306
  20. Grobbee DE, Bots ML. Carotid intima-media thickness as an indicator of generalized atherosclerosis. Journal of Internal Medicine. 1994;236:567–573
  21. Hirai FE, Moss SE, et al. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care. 2008;31(3):493–497
  22. Ishizaka N, Ishizaka Y, et al. Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose tolerance. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23(2):295–301
  23. Jorgensen L, Jenssen T, et al. Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: The Tromso Study. Circulation. 2004;110(4):466–470
  24. Koenig R, Peterson C, et al. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. New England Journal of Medicine. 1976;295(8):417–420
  25. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47(6):859–866
  26. Kumeda Y, Inaba M, et al. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clinical Endocrinology. 2008;69(4):556–561
  27. Laurent S, Boutouyrie P, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236–1241
  28. Lefebvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabetic Medicine. 1998;15(S4):S63–S68
  29. McCance DR, Ritchie CM, et al. Is HbA1 measurement superfluous in NIDDM?. Diabetes Care. 1988;11:512–514
  30. O'Leary DH, Polak JF, et al. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New England Journal of Medicine. 1999;340:14–22
  31. Onbas O, Kantarci M, et al. Carotid intima-media thickness: Is it correlated with stroke side?. Acta Neurologica Scandinavica. 2005;111:169–171
  32. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 1990;15(4):339–347
  33. Selvin E, Coresh J, et al. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes. Diabetes Care. 2005;28(8):1965–1973
  34. Selvin E, Marinopoulos S, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Annals of Internal Medicine. 2004;141(6):421–431
  35. Selvin E, Wattanakit K, et al. HbA1c and peripheral arterial disease in diabetes. Diabetes Care. 2006;29(4):877–882
  36. Shichiri M, Kishikawa H, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23:B21–B29
  37. Taniwaki H, Kawagishi T, et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care. 1999;22(11):1851–1857
  38. Temelkova-Kurktschiev TS, Koehler C, et al. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care. 1999;22(2):333–338
  39. Temelkova-Kurktschiev TS, Koehler C, et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23:1830–1834
  40. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14):977–986
  41. The Diabetes Control and Complications Trial Research Group . Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. American Journal of Cardiology. 1995;75(14):894–903
  42. The Diabetes Control and Complications Trial Research Group . The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–983
  43. The Diabetes Control and Complications Trial Research Group . The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes. 1996;45:1289–1298
  44. UK Prospective Diabetes Study Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853
  45. Touboul PJ, Elbaz A, et al. Common carotid artery intima-media thickness and brain infarction. GENIC case-control study. Circulation. 2000;102:313–318
  46. Tsivgoulis G, Vemmos K, et al. Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke. 2006;37:1913–1916
  47. UK Prospective Diabetes Study Group J. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999;22:1125–1136
  48. Wild S, Roglic G, et al. Global prevalence of diabetes — Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
  49. Zureik M, Ducimetiere P, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20(6):1622–1629

PII: S1056-8727(09)00132-9

doi: 10.1016/j.jdiacomp.2009.12.001

Journal of Diabetes and Its Complications
Volume 25, Issue 1 , Pages 7-13 , January 2011

Article Tools